Characteristic

Entire cohort

(N = 270)

Primary cancer (n, %)

Head and neck

27 (10)

Lymphoma

48 (17.8)

Breast

58 (21.5)

Colo-rectal

25 (9.3)

Gynecologicoa

20 (7.4)

Lung

43 (15.9)

Gastric

18 (6.7)

Sarchoma

5 (1.9)

Melanoma

10 (3.7)

Neuroendorine

3 (1.1)

Others

13 (4.9)

Treatment (n, %)

No treatment

79 (29.3)

Surgery

32 (11.9)

Chemotherapy

45 (16.7)

Surgery + Chemotherapy

23 (8.5)

Chemotherapy + Radiotherapy

37 (13.7)

Surgery + Radiotherapy

11 (4.1)

Other treatments

43 (15.9)

PET/CT indication (n, %)

Initial staging

85 (31.5)

Monitoring treatment

112 (41.5)

Relapse

73 (27)

PET previous (n, %)

First PET/CT

151 (55.9)

One or more PET/CT

119 (44.1)

Number PET/CT previous (mean, SD)

0.98 (1.52)

Minimum: 0

Maximun: 7